scispace - formally typeset
G

Geza Mozes

Researcher at Mayo Clinic

Publications -  35
Citations -  2246

Geza Mozes is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Aortic aneurysm & Nitric oxide synthase. The author has an hindex of 22, co-authored 35 publications receiving 2157 citations. Previous affiliations of Geza Mozes include University of Rochester.

Papers
More filters
Journal ArticleDOI

The hemodynamics and diagnosis of venous disease.

TL;DR: The venous system is, in many respects, more complex than the arterial system and a thorough understanding of venous anatomy, pathophysiology, and available diagnostic tests is required in the management of acute and chronic venous disorders.
Journal ArticleDOI

Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications.

TL;DR: Endovenous laser therapy and radiofrequency ablation are new, minimally invasive percutaneous endovenous techniques for ablation of the incompetent great saphenous vein and occlusion was achieved in >90% of cases after both EVLT and RFA at 1 month.
Journal ArticleDOI

Extension of saphenous thrombus into the femoral vein: A potential complication of new endovenous ablation techniques

TL;DR: Review of the literature revealed that the incidence of thrombus extension into the common femoral vein or deep vein thrombosis in published clinical series is 0.3% after ELT and 2.1% after RFA, which warrants routine postoperative duplex scanning, more alertness during these procedures, and patient education on this possible complication.
Journal ArticleDOI

Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting.

TL;DR: CEA can be performed in patients at high risk, with stroke and death rates well within accepted standards, and data question the use of CAS as an alternative to CEA, even in patientsat high risk.
Journal ArticleDOI

Ruptured abdominal aortic aneurysms: the excessive mortality rate of conventional repair.

TL;DR: The mortality rate of ruptured AAAs remains excessive, despite improvement over 18 years, and patients older than 80 years with shock or cardiac arrest have the highest mortality rate and should be evaluated for possible endovascular treatment.